Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Cree participates in a conference call hosted by Lake Street » 04:55
06/19/20
06/19
04:55
06/19/20
04:55
CREE

Cree

$59.86 /

-1.03 (-1.69%)

Conference call with…

Conference call with management to be held on June 19 at 10 am hosted by Lake Street.

ShowHide Related Items >><<
CREE Cree
$59.86 /

-1.03 (-1.69%)

CREE Cree
$59.86 /

-1.03 (-1.69%)

06/09/20 Goldman Sachs
Cree downgraded to Neutral from Buy at Goldman Sachs
05/26/20 JMP Securities
Cree upgraded to Outperform from Market Perform at JMP Securities
05/26/20 JMP Securities
Cree upgraded to Outperform from Market Perform at JMP Securities
05/20/20
Fly Intel: Top five analyst upgrades
CREE Cree
$59.86 /

-1.03 (-1.69%)

CREE Cree
$59.86 /

-1.03 (-1.69%)

CREE Cree
$59.86 /

-1.03 (-1.69%)

Conference/Events
Cree participates in a conference call hosted by Lake Street » 09:25
06/18/20
06/18
09:25
06/18/20
09:25
CREE

Cree

$60.89 /

+0.34 (+0.56%)

Conference call with…

Conference call with management to be held on June 19 hosted by Lake Street.

ShowHide Related Items >><<
CREE Cree
$60.89 /

+0.34 (+0.56%)

CREE Cree
$60.89 /

+0.34 (+0.56%)

06/09/20 Goldman Sachs
Cree downgraded to Neutral from Buy at Goldman Sachs
05/26/20 JMP Securities
Cree upgraded to Outperform from Market Perform at JMP Securities
05/26/20 JMP Securities
Cree upgraded to Outperform from Market Perform at JMP Securities
05/20/20
Fly Intel: Top five analyst upgrades
CREE Cree
$60.89 /

+0.34 (+0.56%)

CREE Cree
$60.89 /

+0.34 (+0.56%)

CREE Cree
$60.89 /

+0.34 (+0.56%)

Conference/Events
Cree participates in a conference call with Morgan Stanley » 09:18
06/15/20
06/15
09:18
06/15/20
09:18
CREE

Cree

$61.00 /

+3.08 (+5.32%)

Semiconductors Analyst…

Semiconductors Analyst Hettenbach and Autos Analyst Jonas hold a conference call with CEO Lowe to discuss the role of Silicon Carbide in the adoption of electric vehicles on June 15 at 10 am hosted by Morgan Stanley.

ShowHide Related Items >><<
CREE Cree
$61.00 /

+3.08 (+5.32%)

CREE Cree
$61.00 /

+3.08 (+5.32%)

06/09/20 Goldman Sachs
Cree downgraded to Neutral from Buy at Goldman Sachs
05/26/20 JMP Securities
Cree upgraded to Outperform from Market Perform at JMP Securities
05/26/20 JMP Securities
Cree upgraded to Outperform from Market Perform at JMP Securities
05/20/20
Fly Intel: Top five analyst upgrades
CREE Cree
$61.00 /

+3.08 (+5.32%)

CREE Cree
$61.00 /

+3.08 (+5.32%)

CREE Cree
$61.00 /

+3.08 (+5.32%)

Downgrade
Cree downgraded to Neutral from Buy at Goldman Sachs » 20:26
06/09/20
06/09
20:26
06/09/20
20:26
CREE

Cree

$61.70 /

+0.73 (+1.20%)

Goldman Sachs analyst…

Goldman Sachs analyst Brian Lee downgraded Cree to Neutral from Buy with a higher price target of $56, up from $50. There has been no change to the stock's "secular growth opportunity" story, but the recent strength in shares has made risk-reward less attractive, the analyst tells investors in a research note. Lee adds that he still believes in Cree's secular growth opportunity around "long-term growth in EV adoption and 5G infrastructure build-out", but catalysts over the near term are looking more uncertain.

ShowHide Related Items >><<
CREE Cree
$61.70 /

+0.73 (+1.20%)

CREE Cree
$61.70 /

+0.73 (+1.20%)

05/26/20 JMP Securities
Cree upgraded to Outperform from Market Perform at JMP Securities
05/26/20 JMP Securities
Cree upgraded to Outperform from Market Perform at JMP Securities
05/20/20
Fly Intel: Top five analyst upgrades
05/20/20 JPMorgan
JPMorgan upgrades Cree to Neutral, boosts target to $60 from $40
CREE Cree
$61.70 /

+0.73 (+1.20%)

CREE Cree
$61.70 /

+0.73 (+1.20%)

CREE Cree
$61.70 /

+0.73 (+1.20%)

Over a month ago
Upgrade
Cree upgraded to Outperform from Market Perform at JMP Securities » 06:21
05/26/20
05/26
06:21
05/26/20
06:21
CREE

Cree

$51.74 /

+0.75 (+1.47%)

, VWAGY

Volkswagen

$0.00 /

+ (+0.00%)

, IFNNY

Infineon

$0.00 /

+ (+0.00%)

JMP Securities analyst…

JMP Securities analyst Joseph Osha upgraded Cree (CREE) to Outperform from Market Perform with a $74 price target, citing his valuation analysis. Osha notes that the business may not recover rapidly as the drivers pressuring its Wolfspeed revenue, namely the cessation of the Huawei relationship and a deceleration in China-centered EV demand, remain in place. However, the analyst is also positive on the "magnitude" of the opportunity of Cree's competitive position, citing the strong relationship the company has with Volkswagen (VWAGY) and its key semiconductor supplier Infineon (IFNNY) as he expects its SiC business to be supported by the company's materials.

ShowHide Related Items >><<
VWAGY Volkswagen
$0.00 /

+ (+0.00%)

IFNNY Infineon
$0.00 /

+ (+0.00%)

CREE Cree
$51.74 /

+0.75 (+1.47%)

CREE Cree
$51.74 /

+0.75 (+1.47%)

05/26/20 JMP Securities
Cree upgraded to Outperform from Market Perform at JMP Securities
05/20/20
Fly Intel: Top five analyst upgrades
05/20/20 JPMorgan
JPMorgan upgrades Cree to Neutral, boosts target to $60 from $40
05/20/20 JPMorgan
Cree upgraded to Neutral from Underweight at JPMorgan
VWAGY Volkswagen
$0.00 /

+ (+0.00%)

04/30/20 JPMorgan
Volkswagen price target raised to EUR 150 from EUR 116 at JPMorgan
03/26/20 RBC Capital
Volkswagen price target raised to EUR 175 from EUR 165 at RBC Capital
03/17/20 Baird
Baird says 'great opportunity' to get back involved with Navistar
03/09/20 Cowen
Cowen upgrades Paccar to Market Perform on 'flight to quality'
IFNNY Infineon
$0.00 /

+ (+0.00%)

05/12/20 Goldman Sachs
Infineon downgraded to Neutral from Buy at Goldman Sachs
05/06/20 Deutsche Bank
Infineon price target lowered to EUR 22 from EUR 23 at Deutsche Bank
05/06/20 UBS
Infineon price target raised to EUR 23.50 from EUR 22 at UBS
05/04/20 Citi
Infineon downgraded to Neutral from Buy at Citi
VWAGY Volkswagen
$0.00 /

+ (+0.00%)

IFNNY Infineon
$0.00 /

+ (+0.00%)

CREE Cree
$51.74 /

+0.75 (+1.47%)

VWAGY Volkswagen
$0.00 /

+ (+0.00%)

IFNNY Infineon
$0.00 /

+ (+0.00%)

VWAGY Volkswagen
$0.00 /

+ (+0.00%)

IFNNY Infineon
$0.00 /

+ (+0.00%)

CREE Cree
$51.74 /

+0.75 (+1.47%)

CREE Cree
$51.74 /

+0.75 (+1.47%)

Upgrade
Cree upgraded to Outperform from Market Perform at JMP Securities » 05:17
05/26/20
05/26
05:17
05/26/20
05:17
CREE

Cree

$51.74 /

+0.75 (+1.47%)

JMP Securities analyst…

JMP Securities analyst Joseph Osha upgraded Cree to Outperform from Market Perform with a $74 price target.

ShowHide Related Items >><<
CREE Cree
$51.74 /

+0.75 (+1.47%)

CREE Cree
$51.74 /

+0.75 (+1.47%)

05/20/20
Fly Intel: Top five analyst upgrades
05/20/20 JPMorgan
JPMorgan upgrades Cree to Neutral, boosts target to $60 from $40
05/20/20 JPMorgan
Cree upgraded to Neutral from Underweight at JPMorgan
04/30/20 Roth Capital
Cree price target raised to $55 from $50 at Roth Capital
CREE Cree
$51.74 /

+0.75 (+1.47%)

CREE Cree
$51.74 /

+0.75 (+1.47%)

CREE Cree
$51.74 /

+0.75 (+1.47%)

Upgrade
Fly Intel: Top five analyst upgrades » 10:06
05/20/20
05/20
10:06
05/20/20
10:06
LOGI

Logitech

$56.84 /

+1.17 (+2.10%)

, UGP

Ultrapar

$2.78 /

+0.175 (+6.72%)

, GPRE

Green Plains

$8.87 /

+1.87 (+26.71%)

, FMS

Fresenius Medical

$41.01 /

+1.275 (+3.21%)

, CREE

Cree

$52.90 /

+3.25 (+6.55%)

Catch up on today's…

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Logitech (LOGI) upgraded to Neutral from Sell at UBS. 2. Ultrapar (UGP) upgraded to Buy from Neutral at Goldman Sachs with analyst Bruno Amorim saying the stock's 41% selloff year-to-date has already priced in the COVID impact on Ipiranga. 3. Green Plains (GPRE) upgraded to Buy from Hold at Jefferies with analyst Laurence Alexander saying the company has shifted to a hybrid model, with low-cost ethanol assets supporting new, higher-value grades of alternative proteins, and this is slowly being accepted by investors. 4. Fresenius Medical (FMS) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Michael Jungling saying he sees reduced risk to the company's guidance amid increasing volumes of renal replacement therapy as a COVID-19 side effect. 5. Cree (CREE) upgraded to Neutral from Underweight at JPMorgan with analyst Paul Coster saying the company's near-term prospects "look quite poor" owing to COVID-19's impact on electric vehicle demand, but Cree's transition to electric vehicles, 5G and electrification is only delayed, not stopped by the pandemic's near-term disruption. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
LOGI Logitech
$56.84 /

+1.17 (+2.10%)

GPRE Green Plains
$8.87 /

+1.87 (+26.71%)

FMS Fresenius Medical
$41.01 /

+1.275 (+3.21%)

CREE Cree
$52.90 /

+3.25 (+6.55%)

LOGI Logitech
$56.84 /

+1.17 (+2.10%)

05/20/20 UBS
Logitech upgraded to Neutral from Sell at UBS
05/13/20 UBS
Logitech price target raised to CHF 40 from CHF 37 at UBS
05/04/20 Wedbush
Logitech price target raised to $57 from $48 at Wedbush
04/27/20 Loop Capital
Xerox, Park City, NetApp, HP Enterprise cut to Hold from Buy at Loop Capital
UGP Ultrapar
$2.78 /

+0.175 (+6.72%)

05/20/20 Goldman Sachs
Ultrapar upgraded to Buy from Neutral at Goldman Sachs
05/13/20 HSBC
Ultrapar downgraded to Hold from Buy at HSBC
03/31/20 BofA
Ultrapar upgraded to Buy from Neutral at BofA
02/10/20 Citi
Ultrapar upgraded to Buy at Citi
GPRE Green Plains
$8.87 /

+1.87 (+26.71%)

05/20/20 Jefferies
Jefferies upgrades Green Plains to Buy with $16 price target
05/20/20 Jefferies
Green Plains upgraded to Buy from Hold at Jefferies
05/05/20 Roth Capital
Green Plains price target lowered to $11 from $18 at Roth Capital
05/05/20 BMO Capital
Green Plains price target lowered to $13 from $25 at BMO Capital
FMS Fresenius Medical
$41.01 /

+1.275 (+3.21%)

05/20/20 Morgan Stanley
Fresenius Medical upgraded to Equal Weight from Underweight at Morgan Stanley
05/19/20 JPMorgan
Fresenius Medical price target lowered to EUR 84.20 from EUR 90.80 at JPMorgan
05/14/20 Kepler Cheuvreux
Fresenius Medical upgraded to Buy from Hold at Kepler Cheuvreux
04/27/20 Barclays
Fresenius Medical price target lowered to EUR 81 from EUR 84 at Barclays
CREE Cree
$52.90 /

+3.25 (+6.55%)

05/20/20 JPMorgan
JPMorgan upgrades Cree to Neutral, boosts target to $60 from $40
05/20/20 JPMorgan
Cree upgraded to Neutral from Underweight at JPMorgan
04/30/20 Roth Capital
Cree price target raised to $55 from $50 at Roth Capital
04/03/20 Canaccord
Cree price target lowered to $44 from $55 at Canaccord
LOGI Logitech
$56.84 /

+1.17 (+2.10%)

GPRE Green Plains
$8.87 /

+1.87 (+26.71%)

FMS Fresenius Medical
$41.01 /

+1.275 (+3.21%)

CREE Cree
$52.90 /

+3.25 (+6.55%)

GPRE Green Plains
$8.87 /

+1.87 (+26.71%)

LOGI Logitech
$56.84 /

+1.17 (+2.10%)

CREE Cree
$52.90 /

+3.25 (+6.55%)

LOGI Logitech
$56.84 /

+1.17 (+2.10%)

CREE Cree
$52.90 /

+3.25 (+6.55%)

Upgrade
JPMorgan upgrades Cree to Neutral, boosts target to $60 from $40 » 05:59
05/20/20
05/20
05:59
05/20/20
05:59
CREE

Cree

$49.65 /

+0.28 (+0.57%)

JPMorgan analyst Paul…

JPMorgan analyst Paul Coster upgraded Cree to Neutral from Underweight with a price target of $60, up from $40. The company's near-term prospects "look quite poor" owing to COVID-19's impact on electric vehicle demand, but Cree's transition to electric vehicles, 5G and electrification is only delayed, not stopped by the pandemic's near-term disruption, Coster tells investors in a research note. As such, the analyst anticipates strong demand for the company's Wolfspeed silicon carbide materials and power modules materializing in fiscal 2023. Cree stock looks attractively valued here, says Coster.

ShowHide Related Items >><<
CREE Cree
$49.65 /

+0.28 (+0.57%)

CREE Cree
$49.65 /

+0.28 (+0.57%)

05/20/20 JPMorgan
Cree upgraded to Neutral from Underweight at JPMorgan
04/30/20 Roth Capital
Cree price target raised to $55 from $50 at Roth Capital
04/03/20 Canaccord
Cree price target lowered to $44 from $55 at Canaccord
04/01/20
Fly Intel: Top five analyst upgrades
CREE Cree
$49.65 /

+0.28 (+0.57%)

CREE Cree
$49.65 /

+0.28 (+0.57%)

CREE Cree
$49.65 /

+0.28 (+0.57%)

Upgrade
Cree upgraded to Neutral from Underweight at JPMorgan » 05:05
05/20/20
05/20
05:05
05/20/20
05:05
CREE

Cree

$49.65 /

+0.28 (+0.57%)

JPMorgan analyst Paul…

JPMorgan analyst Paul Coster upgraded Cree to Neutral from Underweight with a $60 price target.

ShowHide Related Items >><<
CREE Cree
$49.65 /

+0.28 (+0.57%)

CREE Cree
$49.65 /

+0.28 (+0.57%)

04/30/20 Roth Capital
Cree price target raised to $55 from $50 at Roth Capital
04/03/20 Canaccord
Cree price target lowered to $44 from $55 at Canaccord
04/01/20
Fly Intel: Top five analyst upgrades
04/01/20 Piper Sandler
Cree upgraded to Neutral from Underweight at Piper Sandler
CREE Cree
$49.65 /

+0.28 (+0.57%)

CREE Cree
$49.65 /

+0.28 (+0.57%)

CREE Cree
$49.65 /

+0.28 (+0.57%)

Recommendations
Cree price target raised to $55 from $50 at Roth Capital » 08:47
04/30/20
04/30
08:47
04/30/20
08:47
CREE

Cree

$46.26 /

+4.81 (+11.60%)

Roth Capital analyst…

Roth Capital analyst Craig Irwin raised the firm's price target on Cree to $55 from $50 and keeps a Buy rating on the shares. The analyst notes that Cree reported challenged Q3 results in-line with consensus, and issued guidance reflecting building headwinds in Q4. Management confirmed auto OEMs aren't slowing plans for new BEV development while they work through their own challenges, he adds. As the leading supplier of SiC materials and devices used in BEVs, Irwin believes this gives high visibility for Cree achieving rebounding growth in a Post COVID-19 environment.

ShowHide Related Items >><<
CREE Cree
$46.26 /

+4.81 (+11.60%)

04/03/20 Canaccord
Cree price target lowered to $44 from $55 at Canaccord
04/01/20
Fly Intel: Top five analyst upgrades
04/01/20 Piper Sandler
Cree upgraded to Neutral from Underweight at Piper Sandler
03/30/20 Canaccord
Cree positioned to capture future SiC growth, says Canaccord

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.